The acquisition expands Aurora's production capacity in the high-margin international medical cannabis market. Traders should monitor integration progress and the timeline for realizing operational efficiencies and EBITDA contributions. The share issuance represents modest dilution.
Price Chart
Executive Summary
Aurora Cannabis acquired Safari Flower Company for $26.5 million to expand its EU GMP-certified cultivation capacity, aiming to strengthen its position in high-margin international medical cannabis markets. The acquisition is expected to be accretive with positive Adjusted EBITDA contributions starting in fiscal 2027.
Key Facts
- Aurora Cannabis acquired Safari Flower Company for $26.5 million
- The acquisition includes a 59,000 square foot EU GMP-certified facility in Ontario, Canada
- The deal is expected to deliver positive Adjusted EBITDA contributions in fiscal 2027
- Aurora issued 2,417,180 common shares and paid $15 million in cash at closing
- The acquired capacity will supply EU GMP flower to key markets including Germany, Australia, Poland, and the UK
Financial Impact
The transaction is valued at $26.5 million, with $15 million paid in cash and 2,417,180 shares issued. Expected to deliver positive Adjusted EBITDA contributions starting in fiscal 2027.
Risk Factors
- Integration risks of the acquired business
- Ability to realize projected operational efficiencies and synergies
- Execution risk in optimizing the new assets within Aurora's supply network
- Potential market reaction to the share issuance and dilution
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001279569-26-000304 |
| Document: aurora_6k.htm | 0001279569-26-000304 |
| Document: 0001279569-26-000304-index-headers.html | 0001279569-26-000304 |
| Document: 0001279569-26-000304-index.html | 0001279569-26-000304 |
| Document: 0001279569-26-000304.txt | 0001279569-26-000304 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 6-K | $3.87 | awaiting T+5 | — | $3.90 (+0.78%) |
Oct 14, 2026 12d ago | 6-K | $4.10 $3.97 | ▼ −3.17% | ▼ −2.16% | $3.90 (−4.88%) |
Oct 8, 2026 18d ago | 6-K | $4.43 $4.10 | ▼ −7.45% | ▼ −7.17% | $3.90 (−11.96%) |
Oct 6, 2026 20d ago | 6-K | $4.46 $4.17 | ▼ −6.50% | ▼ −5.52% | $3.90 (−12.56%) |
Oct 5, 2026 20d ago | 6-K | $4.59 $4.29 | ▼ −6.54% | ▼ −6.40% | $3.90 (−15.03%) |
Sep 16, 2026 5w ago | 6-K | $3.83 $4.22 | ▲ +10.18% | ▲ +7.62% | $3.90 (+1.83%) |
Sep 14, 2026 6w ago | 6-K | $3.81 $4.03 | ▲ +5.77% | ▲ +5.67% | $3.90 (+2.36%) |
Sep 9, 2026 6w ago | 6-K | $3.88 $3.83 | ▼ −1.29% | ▼ −0.63% | $3.90 (+0.52%) |
Sep 2, 2026 7w ago | 6-K | $4.03 $3.73 | ▼ −7.44% | ▼ −6.49% | $3.90 (−3.23%) |
Aug 24, 2026 9w ago | 6-K | $3.94 $4.05 | ▲ +2.79% | ▲ +2.32% | $3.90 (−1.02%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers